TowerJazz Announces Successful Completion of Non-Convertible Unsecured Bonds Institutional Tender
May 31, 2016 07:07 am UTC| Business
Received Binding Commitments of $100 Million from Israeli Institutional Investors for Long Term Non-Convertible Unsecured Bonds Maturing in 2023 Proceeds to Be Used For the Early Repayment of Its Outstanding $78 Million...
FRONTLINE LTD. REPORTS RESULTS FOR THE FIRST QUARTER 2016
May 31, 2016 06:58 am UTC| Business
HAMILTON, Bermuda, May 31, 2016 -- Frontline Ltd. (the "Company" or "Frontline"), today reported unaudited results for the three months ended March 31, 2016: Highlights Achieved net income attributable to the...
Nanobiotix establishes promising preclinical proof-of-concept in Immuno Oncology
May 31, 2016 06:09 am UTC| Business
Small but heading for the big time Nanobiotix establishes promising preclinical proof-of-concept in Immuno Oncology PARIS and CAMBRIDGE, Mass., May 31, 2016 --NANOBIOTIX (Euronext: NANO - ISIN: FR0011341205), a late...
Targovax to present at forthcoming conferences
May 31, 2016 06:05 am UTC| Business
OSLO, Norway, May 31, 2016 -- Targovax, a clinical stage immuno-oncology company, developing targeted immunotherapy treatments for cancer patients, announces that members of its senior management team will participate in...
May 31, 2016 05:39 am UTC| Business
PARIS, May 31, 2016 -- CGG announced today that Sercel has delivered two of its new-generation 508XT land seismic acquisition systems, representing a total of 12,000 channels, to Bashneftegeofizika, one of the largest oil...
May 31, 2016 05:07 am UTC| Business
BAGNEUX, France, May 31, 2016 -- DBV Technologies and Nestl Health Science Form Collaboration to Develop and Commercialize a Novel Diagnostic Test for Pediatric Milk Allergy Collaboration will support DBV's Mission...
May 30, 2016 20:47 pm UTC| Business
MONTROUGE, France, May 30, 2016 -- DBV Technologies, (Euronext: DBV - ISIN: FR0010417345 - NASDAQ: DBVT), a clinical-stage specialty biopharmaceutical company, announces that it will hold its Mixed General Assembly on...